良性海绵窦脑膜瘤接受LINAC立体定向放射外科治疗后颅神经神经病变的恢复
本研究在单中心纳入2005至2020年接受LINAC立体定向放射外科或分次立体定向放疗的128例海绵窦脑膜瘤患者,其中46例存在颅神经神经病变。中位随访53.4个月,全部病例达到影像学肿瘤控制,80.4%的患者颅神经神经病变恢复,治疗前肿瘤体积较小与恢复率较高相关,中位改善时间为3.7个月。
要点
- 海绵窦脑膜瘤患者接受LINAC立体定向放射外科或分次立体定向放疗后,80.4%的颅神经神经病变恢复。
- 治疗前肿瘤体积较小与颅神经神经病变恢复率较高相关(p < 0.001),中位改善时间为3.7个月。
- 肿瘤体积超过6.8 cc及接受分次立体定向放疗者改善时间延长(分别为P < 0.03和P < 0.04)。
核心结论
- 本研究提示,立体定向放射外科或分次立体定向放疗治疗海绵窦脑膜瘤可获得良好且持久的颅神经神经病变恢复效果,并具有优异的长期影像学控制。
- 治疗前肿瘤体积较小与颅神经神经病变恢复率较高相关。
- 与分次立体定向放疗相比,接受立体定向放射外科治疗的患者改善时间更短,尤其在治疗前肿瘤体积较小的患者中。
研究设计与样本
- 单中心研究,纳入2005年至2020年间接受LINAC立体定向放射外科或分次立体定向放疗的128例海绵窦脑膜瘤患者,其中46例存在颅神经神经病变。
- 46例中25例接受立体定向放射外科治疗,21例接受分次立体定向放疗。
主要发现
- 中位随访时间为53.4个月。
- 治疗前平均肿瘤体积为9.5 cc,末次随访时平均肿瘤体积降至5.1 cc。
- 全部病例达到影像学肿瘤控制。
- 80.4%的患者观察到颅神经神经病变恢复,具体神经恢复情况为:眼外神经43.2%、三叉神经32.4%、视神经10.8%。
- 治疗前肿瘤体积较小与颅神经神经病变恢复率较高相关(p < 0.001),中位改善时间为3.7个月。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Cranial Nerve Neuropathies (CNNs) often accompany Cavernous Sinus Meningioma (CSM), for which Stereotactic Radiosurgery (SRS) or fractionated stereotactic radiotherapy (FSR) are established treatments. This study assesses CNNs recovery in CSM patients treated with LINAC, offering insight into treatment effectiveness. METHODS: This study was conducted on 128 patients with CSM treated with LINAC-based SRS/FSR between 2005 and 2020 at a single institution. 46 patients presented with CNNs. The study analyzed patients' demographics, clinical parameters, SRS/FSR treatment characteristics, post-treatment CNNs recovery duration, status, and radiological control on their last follow-up. RESULTS: The median follow-up duration was 53.4 months. Patients were treated with SRS (n = 25) or FSR (n = 21). The mean pretreatment tumor volume was 9.5 cc decreasing to a mean end-of-follow-up tumor volume was 5.1 cc. Radiological tumor control was achieved in all cases. CNN recovery was observed in 80.4% of patients, with specific nerve recoveries documented as follows: extra-ocular nerves (43.2%), trigeminal nerve (32.4%), and optic nerve (10.8%). A higher CNNs recovery rate was associated with a smaller pre-treatment tumor volume (p < 0.001), and the median time-to-improvement was 3.7 months. Patients with tumor volumes exceeding 6.8 cc and those treated with FSR exhibited prolonged time-to-improvement (P < 0.03 and P < 0.04 respectively). CONCLUSIONS: This study suggests that SRS/FSR for CSM provides good and sustainable CNNs recovery outcomes with excellent long-term radiological control. A higher CNNs recovery rate was associated with a smaller pre-treatment tumor volume. while shorter time-to-improvement was identified in patients treated with SRS compared to FSR, particularly in those with small pre-treatment tumor volume.
引用
- Kaisman-Elbaz T, Blumenfeld P, Wygoda M, et al. Recovery of cranial nerve neuropathies after LINAC-based stereotactic radiosurgery for benign cavernous sinus meningioma. J Neurooncol. 2024. PMID: 39088156. doi:10.1007/s11060-024-04783-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。